SP 500 Edges Higher as Healthcare and Tech Lead Comms Stands Alone Manchester City Faces Strategic Rebuild Following Bernardo Silvas Departure Applied Digital Price Target Raised by 3 at Needham What It Signals Sebi Chief Tuhin Kanta Pandey Advocates for Bond ETFs and Tokenisation as Corporate Debt Fundraising Approaches Rs 9 Lakh Crore Traders Signal Potential US Government Stakes in IonQ Micron and Anduril Bloom Energy Shares Surge on 26 Billion AI Infrastructure Deal with Nebius FE Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges Stock Holds Steady Datasea Inc DTSS Q2 2022 Earnings WiderThanExpected Loss as Stock Surges PED Q1 2026 Earnings Strong EPS Beat Offsets Investor Caution Amid Revenue Gap ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress NiSource NI Q1 2026 Earnings Earnings Miss the Mark but Stock Edges Higher Cable One Inc CABO Q1 2026 Earnings EPS Surpasses Estimates Amid Unreported Revenue Milestone Pharmaceuticals MIST Slides 724 as Selling Pressure BuildsKey Support at 134 in Focus Post Holdings POST Holds Steady Near 9650 Testing Key Resistance Zone Lifeward Ltd LFWD Surges Over 11 as Shares Test Key Resistance Four Seasons Education FEDU Surges 79 as Stock Tests Key Resistance Near 1146 Blackrock Enhanced Global Dividend Trust BOE Holds Steady Near Support as Global Markets Offer Mixed Signals Bessent Foresees Substantial Disinflation as Warsh Takes Helm at Federal Reserve ARBK Q2 2024 Earnings Bitcoin Mining Headwinds Persist as EPS Misses Amid Unreported Revenue ChipMOS Technologies IMOS Gains Momentum A Strong Session Above Key Support Golar LNG Drops 255 as Pressure Builds Key Support at 4797 in Focus Planet Green Holdings Corp PLAG Slips 3 as Stock Tests Key Support at 150 Rocky Mountain Chocolate Factory RMCF Surges 415 as Shares Approach Key Resistance at 211 Virtus Dividend Interest Premium Strategy Fund NFJ Rises 125 as Dividend Appeal Drives Demand Pantages Capital Acquisition Rights PGACR Hovering at 021 Amid Minimal Price Movement RGC Resources RGCO Edges Higher Amid Tight Trading Range Gyre Therapeutics GYRE Declines 31 as Stock Tests Key Support Near 545